Current status of peptic ulcer therapy
Lux, G.
Medizinische Klinik 73(8): 261-270
1978
ISSN/ISBN: 0025-8458 PMID: 342884 Document Number: 137148
Document emailed within 1 workday
Related Documents
Koch, H. 1974: Current aspects of peptic ulcer therapy Die Medizinische Welt 25(12): 491-493Ryss, E.S.; Fishzon-Ryss, I.I. 1989: Current drug therapy of peptic ulcer Klinicheskaia Meditsina 67(1): 49-55
Boixeda De Miquel, D.; Martín De Argila, C. 2002: Current therapy of Helicobacter pylori infection in peptic ulcer disease (first part) Revista Clinica Espanola 202(9): 492-494
Baron, J.H. 1982: Current views on pathogenesis of peptic ulcer Scandinavian Journal of Gastroenterology. Supplement 80: 1-10
Bralow, S.P. 1972: Current management of peptic ulcer disease. I Delaware Medical Journal 44(7): 179-187
Marzec, B.; Kowalczyk, L. 1982: Current theories on the treatment of peptic ulcer perforation Wiadomosci Lekarskie 35(22): 1419-1422
Grigor'ev, P.Ia.; Isakov, V.A. 1990: Current views on the etiology and pathogenesis of peptic ulcer Vestnik Akademii Meditsinskikh Nauk SSSR 1990(3): 60-64
Deredzhian, K.; Kolarov, E. 1986: Current aspects of the surgical treatment of peptic ulcer Khirurgiia 39(2): 53-61
Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123
Tagliacozzo, S.; Dragone, G. 1977: Current trends in the treatment of peptic ulcer. Gastric resection Minerva Medica 68(55): 3733-3744
Oparin, A.G.; Fedchenko, I.G. 1987: Status of the autonomic nervous system of peptic ulcer patients Vrachebnoe Delo 6: 29-31
Plastinina, R.A.; Trusov, V.V. 1970: Status of the resorptive function of the small intestine in peptic ulcer Sovetskaia Meditsina 33(3): 87-90
Kulyga, V.N.; Malov, I.S.; Paskhina, M.N.; Dudarenko, S.V. 1986: Status of local humoral immunity in peptic ulcer patients Vrachebnoe Delo 5: 14-16
Miagkova, L.P.; Alekperov, R.T. 1991: Status of the immune system and the reparative processes in peptic ulcer Klinicheskaia Meditsina 69(8): 26-30
Krivitskiĭ, D.I.; Shuliarenko, V.A.; Paratsiĭ, Z.Z.; Baĭmut, V.I.; Gvozdiak, N.N. 1988: Status of immunological reactivity in patients with peptic ulcer complicated by perforation Vrachebnoe Delo 6: 67-69
Ruzyłło, E.; Godziemba-Maliszewska, E.; Tacikowski, T. 1990: Natural history of peptic ulcer disease in Poland. Part VIII. Peptic ulcer disease and diseases of the liver, bile ducts and gallbladder Materia Medica Polona. Polish Journal of Medicine and Pharmacy 22(3): 225-232
Lorusso, D.; Pezzolla, F.; Lantone, G.; Misciagna, G.; Guerra, V. 1997: Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists Minerva Chirurgica 52(11): 1293-1297
Brooks, W.S. 1992: Short- and long-term management of peptic ulcer disease: current role of H2-antagonists Hepato-Gastroenterology 39(Suppl 1): 47-52
Serebrianskaia, N.V.; Fokina, T.S.; Maksimova, I.E.; Belokrinitskiĭ, D.V. 1991: Status of cellular immunity in patients with peptic ulcer and different degree of acidity of gastric juice Klinicheskaia Meditsina 69(7): 62-63
Bethke, P.L.; Palme, G. 1971: Therapy of peptic ulcer using carbenoxolone Die Medizinische Welt 47: 1892-1894